Tarsus Pharmaceuticals, Inc. (TARS)
64.76
+3.47
(+5.66%)
USD |
NASDAQ |
May 20, 16:00
64.76
0.00 (0.00%)
After-Hours: 20:00
Tarsus Pharmaceuticals EPS Diluted (Quarterly) : -0.1622 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Harrow, Inc. | -0.7414 |
| Eton Pharmaceuticals, Inc. | 0.0493 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.967M |
| Revenue (Quarterly) | 162.05M |
| Total Expenses (Quarterly) | 169.02M |
| Enterprise Value | 2.337B |
| Gross Profit Margin (Quarterly) | 94.20% |
| Profit Margin (Quarterly) | -4.30% |
| Earnings Yield | -1.75% |
| Normalized Earnings Yield | -1.750 |